Makrecka-Kuka, M., Korzh, S., Videja, M., Vilks, K., Cirule, H., Kuka, J., . . . Liepinsh, E. (2020). Empagliflozin Protects Cardiac Mitochondrial Fatty Acid Metabolism in a Mouse Model of Diet-Induced Lipid Overload. Cardiovascular drugs and therapy, 34(6), 791-797. https://doi.org/10.1007/s10557-020-06989-9
Chicago-Zitierstil (17. Ausg.)Makrecka-Kuka, Marina, Stanislava Korzh, Melita Videja, Karlis Vilks, Helena Cirule, Janis Kuka, Maija Dambrova, und Edgars Liepinsh. "Empagliflozin Protects Cardiac Mitochondrial Fatty Acid Metabolism in a Mouse Model of Diet-Induced Lipid Overload." Cardiovascular Drugs and Therapy 34, no. 6 (2020): 791-797. https://doi.org/10.1007/s10557-020-06989-9.
MLA-Zitierstil (9. Ausg.)Makrecka-Kuka, Marina, et al. "Empagliflozin Protects Cardiac Mitochondrial Fatty Acid Metabolism in a Mouse Model of Diet-Induced Lipid Overload." Cardiovascular Drugs and Therapy, vol. 34, no. 6, 2020, pp. 791-797, https://doi.org/10.1007/s10557-020-06989-9.